News | May 24, 2025
Glenmark Pharma reports Q4 FY25 PAT at Rs. 346.6 Cr
Adjusted Profit After Tax (PAT) for the year ended March 31, 2025 was at Rs. 1,389.4 crore
Adjusted Profit After Tax (PAT) for the year ended March 31, 2025 was at Rs. 1,389.4 crore
Sun Pharma will invest up to $25 million in US-based Pharmazz Inc, raising its stake to 22.7%
Amlodipine and Atorvastatin tablets are indicated in patients for whom treatment with both amlodipine and atorvastatin
Record international participation reflects renewed momentum in pharma manufacturing and global sourcing, as easing tariffs fuel growth
Allopurinol is used to prevent or lower high uric acid levels in the blood
Isotretinoin capsules are indicated to treat severe, disfiguring nodular acne
Certification bolsters Venus Remedies' position in PIC/S markets, reinforcing commitment to global quality standards
The company was awarded the insulins supply contract for a three-year period in 2022 through April 2025
Merck KGaA, Darmstadt, Germany announced the presentation of new oncology data across more than 12 tumor types at ASCO 2025
The company has posted net profit of Rs. 40.88 crores for the Financial Year ended March 31, 2025
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
